Journal article icon

Journal article

Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies

Abstract:
Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, -42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.2807/1560-7917.ES.2018.23.9.18-00086

Authors


Expand authors...

Contributors

Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Primary Care Health Sciences
Department:
Unknown
Role:
Contributor
Publisher:
European Centre for Disease Prevention and Control Publisher's website
Journal:
Eurosurveillance Journal website
Volume:
23
Issue:
9
Publication date:
2018-03-01
Acceptance date:
2018-03-01
DOI:
EISSN:
1560-7917
ISSN:
1025-496X
Pmid:
29510782
Source identifiers:
1014057

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP